ATE147381T1 - Verfahren zur gewinnung von 10-deacetylbaccatin- iii - Google Patents

Verfahren zur gewinnung von 10-deacetylbaccatin- iii

Info

Publication number
ATE147381T1
ATE147381T1 AT93921986T AT93921986T ATE147381T1 AT E147381 T1 ATE147381 T1 AT E147381T1 AT 93921986 T AT93921986 T AT 93921986T AT 93921986 T AT93921986 T AT 93921986T AT E147381 T1 ATE147381 T1 AT E147381T1
Authority
AT
Austria
Prior art keywords
obtaining
deacetylbaccatin
iii
yew
deacetylbaccatin iii
Prior art date
Application number
AT93921986T
Other languages
English (en)
Inventor
Rodolphe Margraff
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Application granted granted Critical
Publication of ATE147381T1 publication Critical patent/ATE147381T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epoxy Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Extraction Or Liquid Replacement (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Polyoxymethylene Polymers And Polymers With Carbon-To-Carbon Bonds (AREA)
AT93921986T 1992-10-05 1993-10-04 Verfahren zur gewinnung von 10-deacetylbaccatin- iii ATE147381T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9211745A FR2696462B1 (fr) 1992-10-05 1992-10-05 Procédé d'obtention de la désacétyl-10 baccatine III.

Publications (1)

Publication Number Publication Date
ATE147381T1 true ATE147381T1 (de) 1997-01-15

Family

ID=9434123

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93921986T ATE147381T1 (de) 1992-10-05 1993-10-04 Verfahren zur gewinnung von 10-deacetylbaccatin- iii

Country Status (30)

Country Link
US (2) US5393896A (de)
EP (1) EP0663909B1 (de)
JP (1) JP3299753B2 (de)
KR (1) KR100301238B1 (de)
CN (1) CN1041310C (de)
AT (1) ATE147381T1 (de)
AU (1) AU680440B2 (de)
CA (2) CA2470124C (de)
CZ (2) CZ286452B6 (de)
DE (1) DE69307333T2 (de)
DK (1) DK0663909T3 (de)
EE (1) EE03124B1 (de)
ES (1) ES2095672T3 (de)
FI (1) FI109797B (de)
FR (1) FR2696462B1 (de)
GE (1) GEP19981433B (de)
GR (1) GR3022229T3 (de)
HU (1) HU225969B1 (de)
LT (1) LT3465B (de)
LV (1) LV10620B (de)
MX (1) MX9305770A (de)
NO (1) NO310414B1 (de)
NZ (1) NZ256449A (de)
PL (1) PL173993B1 (de)
RU (1) RU2108330C1 (de)
SK (1) SK280335B6 (de)
TW (1) TW404944B (de)
UA (1) UA40601C2 (de)
WO (1) WO1994007881A1 (de)
ZA (1) ZA937312B (de)

Families Citing this family (86)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435002T2 (de) 1993-07-19 2008-03-20 Angiotech Pharmaceuticals, Inc., Vancouver Anti-angiogene Mittel enthaltend Taxol und einen nicht biodegradierbaren Träger und deren Verwendung
FR2714053B1 (fr) * 1993-12-22 1996-03-08 Pf Medicament Procédé d'extraction et d'isolement de la 10-désacétylbaccatine III.
CN1112433A (zh) * 1994-05-24 1995-11-29 郭明 红豆杉属植物提取物及其应用
AU716005B2 (en) 1995-06-07 2000-02-17 Cook Medical Technologies Llc Implantable medical device
FR2736355B1 (fr) * 1995-07-07 1997-11-07 Pf Medicament Procede d'extraction et d'isolement de la 10-desacetylbaccatine iii
US5965752A (en) * 1996-08-23 1999-10-12 Institut National De La Recherche Scientifique Preparative scale isolation and purification of taxanes
ATE234800T1 (de) 1997-08-21 2003-04-15 Univ Florida State Verfahren zur synthese von taxanen
US6066748A (en) * 1997-12-17 2000-05-23 Han; Man Woo Process of extracting TAXOL® from taxus cuspidata
ATE219070T1 (de) 1998-01-14 2002-06-15 Bristol Myers Squibb Co Neue kristallkomplexe von baccatin iii mit imidazol, 2-methylimidazol or isopropanol
US6136989A (en) * 1998-12-30 2000-10-24 Phytogen Life Sciences, Incorporated Method for high yield and large scale extraction of paclitaxel from paclitaxel-containing material
US5969165A (en) * 1999-01-07 1999-10-19 508037 (Nb) Inc. Isolation and purification of paclitaxel and other related taxanes by industrial preparative low pressure chromatography on a polymeric resin column
US6495705B2 (en) 2000-03-16 2002-12-17 Napro Biotherapeutics, Inc. Efficient process for the production of 10-DAB III by selective hydrazinolysis of various taxanes
US6281368B1 (en) 2000-03-16 2001-08-28 Napro Biotherapeutics, Inc. Simple and efficient hydrazinolysis of C-10 and C-13 ester functionalities of taxanes to obtain 10-DAB III
CA2307393A1 (en) 2000-05-01 2001-11-01 The University Of British Columbia Ginsenoside chemotherapy
IT1320107B1 (it) * 2000-11-28 2003-11-18 Indena Spa Procedimento per la preparazione di derivati tassanici.
US20030157170A1 (en) * 2001-03-13 2003-08-21 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
US20030054036A1 (en) * 2001-03-13 2003-03-20 Richard Liggins Micellar drug delivery vehicles and precursors thereto and uses thereof
DK1392254T3 (da) 2001-04-20 2007-07-02 Univ British Columbia Micelle-lægemiddelindgivelsessystem for hydrofobe lægemidler
US7351542B2 (en) 2002-05-20 2008-04-01 The Regents Of The University Of California Methods of modulating tubulin deacetylase activity
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
AU2003303565A1 (en) * 2002-12-31 2004-07-29 Natural Pharmaceuticals Inc. Pelletizing yew biomass for extraction of taxanes and other natural products
EP1633317A4 (de) 2003-05-16 2008-08-20 Intermune Inc Synthetische chemokin-rezeptor-liganden und anwendungsverfahren dafür
WO2005037329A2 (en) * 2003-10-17 2005-04-28 Tyco Healthcare Group, Lp Surgical stapling device with independent tip rotation
WO2005040758A2 (en) 2003-10-24 2005-05-06 Intermune, Inc. Use of pirfenidone in therapeutic regimens
US20060127510A1 (en) * 2003-12-30 2006-06-15 Natural Pharmaceuticals, Inc. Harvesting and pelletizing yew biomass for extraction of taxanes and other natural products
US7989490B2 (en) 2004-06-02 2011-08-02 Cordis Corporation Injectable formulations of taxanes for cad treatment
US8003122B2 (en) 2004-03-31 2011-08-23 Cordis Corporation Device for local and/or regional delivery employing liquid formulations of therapeutic agents
US7846940B2 (en) 2004-03-31 2010-12-07 Cordis Corporation Solution formulations of sirolimus and its analogs for CAD treatment
US20050250954A1 (en) * 2004-05-04 2005-11-10 Phytogen Life Sciences Inc. Semi-synthesis and isolation of taxane intermediates from a mixture of taxanes
US20050240036A1 (en) * 2004-04-23 2005-10-27 Phytogen Life Sciences Inc. Semi-synthesis of taxane intermediates from a mixture of taxanes
US20050272807A1 (en) * 2004-06-04 2005-12-08 Phytogen Life Sciences Inc. Semi-synthesis of taxane intermediates and their conversion to paclitaxel and docetaxel
ATE421959T1 (de) * 2004-07-02 2009-02-15 Ivax Pharmaceuticals Sro Verfahren zur trennung von paclitaxel und cephalomannin
US7597884B2 (en) 2004-08-09 2009-10-06 Alios Biopharma, Inc. Hyperglycosylated polypeptide variants and methods of use
WO2006089209A2 (en) 2005-02-17 2006-08-24 The Board Of Trustees Of The Leland Stanford Junior University Txr1 and enhanced taxane sensitivity based on the modulation of a pathway mediated thereby
WO2007045093A1 (en) * 2005-10-21 2007-04-26 Her Majesty The Queen In Right Of Canada As Represented By The Minister Of Natural Resources Canada, Canadian Forest Service Preparation of taxanes
RU2448697C2 (ru) 2006-03-22 2012-04-27 Медигене Аг Лечение рака молочной железы, негативного по трем рецепторам
EP2043704B2 (de) 2006-06-30 2017-04-19 Cook Medical Technologies LLC Verfahren zur herstellung und modifizierung von taxan-beschichtungen für implantierbare medizinische vorrichtungen
CN100404520C (zh) * 2006-08-15 2008-07-23 北京诺瑞医药技术有限公司 从欧洲红豆杉枝叶中提取分离10－去乙酰基巴卡汀ⅲ的方法
CN101230053B (zh) * 2007-12-04 2010-06-02 北京诺瑞医药技术有限公司 从红豆杉枝叶中超声提取分离10-去乙酰基巴卡汀ⅲ的方法
US8420110B2 (en) 2008-03-31 2013-04-16 Cordis Corporation Drug coated expandable devices
US8409601B2 (en) 2008-03-31 2013-04-02 Cordis Corporation Rapamycin coated expandable devices
US8273404B2 (en) 2008-05-19 2012-09-25 Cordis Corporation Extraction of solvents from drug containing polymer reservoirs
EP2296645B1 (de) 2008-05-22 2014-11-19 Galera Therapeutics, LLC Antitumorale kombinationstherapie
US20110172293A1 (en) 2008-07-08 2011-07-14 Fish Jason E Methods and Compositions for Modulating Angiogenesis
US8642063B2 (en) 2008-08-22 2014-02-04 Cook Medical Technologies Llc Implantable medical device coatings with biodegradable elastomer and releasable taxane agent
US20120303115A1 (en) 2011-05-25 2012-11-29 Dadino Ronald C Expandable devices coated with a rapamycin composition
US20120302954A1 (en) 2011-05-25 2012-11-29 Zhao Jonathon Z Expandable devices coated with a paclitaxel composition
PL2760848T3 (pl) 2011-09-26 2019-07-31 Fresenius Kabi Oncology Limited Sposoby otrzymywania kabazytakselu powiązane z sililowaniem c(7)-oh i c(13)-oh lub z sililowaniem tylko c(7)-oh
US9956385B2 (en) 2012-06-28 2018-05-01 The Spectranetics Corporation Post-processing of a medical device to control morphology and mechanical properties
WO2014014821A1 (en) 2012-07-19 2014-01-23 Redwood Biosciences, Inc. Antibody specific for cd22 and methods of use thereof
EP2916835A4 (de) 2012-11-12 2016-07-27 Redwood Bioscience Inc Verbindungen und verfahren zur herstellung eines konjugats
PT3613439T (pt) 2013-02-15 2021-05-12 Univ California Recetor de antigénio quimérico e métodos de utilização do mesmo
KR20150135332A (ko) 2013-03-14 2015-12-02 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 미토콘드리아 알데히드 탈수소효소-2 조절인자들 및 이들의 사용 방법
CN103508984B (zh) * 2013-10-22 2017-03-08 北京诺瑞医药技术有限公司 连续浸漉吸附富集法从红豆杉中提取10-dab的方法
CA3178867A1 (en) 2013-11-27 2015-06-04 Redwood Bioscience, Inc. Hydrazinyl-pyrrolo compounds and methods for producing a conjugate
ES2833157T3 (es) 2014-02-19 2021-06-14 Aviv Therapeutics Inc Amidas políciclicas de unión a aldehído deshidrogenasa 2 mitocondrial (aldh2) y su uso para el tratamiento del cáncer
WO2017053920A1 (en) 2015-09-25 2017-03-30 Zy Therapeutics Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
WO2017083637A1 (en) 2015-11-12 2017-05-18 The Board Of Trustees Of The Leland Stanford Junior University Cell-penetrating, guanidinium-rich oligophosphotriesters for drug and probe delivery
HUP1500603A2 (en) * 2015-12-11 2017-06-28 Rotachrom Tech Kft Process for the separation of 10-deacetyl baccatin iii
TWI760319B (zh) 2015-12-30 2022-04-11 杏國新藥股份有限公司 乳癌治療
CN109071634A (zh) 2016-04-26 2018-12-21 R.P.谢勒技术有限责任公司 抗体偶联物及其制备和使用方法
WO2018017190A2 (en) 2016-06-01 2018-01-25 Baxalta Incorporated Formulations of polyalkylene oxide-asparaginase and methods of making and using the same
CN106397371A (zh) * 2016-08-31 2017-02-15 重庆市碚圣医药科技股份有限公司 一种用曼地亚红豆杉高产10‑dabⅲ的方法
TWI852903B (zh) 2017-01-05 2024-08-21 杏國新藥股份有限公司 胰臟癌治療
US12187801B2 (en) 2017-01-18 2025-01-07 Exuma Biotech Corp. Chimeric antigen receptors against AXL or ROR2 and methods of use thereof
EP3388082A1 (de) 2017-04-13 2018-10-17 Galera Labs, LLC Kombinationskrebsimmuntherapie mit makrocyclischem pentaaza-ringkomplex
EP3630189A4 (de) 2017-05-24 2021-06-23 The Board of Regents of The University of Texas System Linker für antikörper-arzneimittelkonjugate
MX2020008028A (es) 2018-01-31 2020-12-11 Galera Labs Llc Terapia de combinacion para cancer con complejo de anillo macrociclico de pentaaza y agente anticancer basado en platino.
AU2019249215B2 (en) 2018-04-06 2026-02-19 The Regents Of The University Of California Methods of treating EGFRvIII expressing glioblastomas
EP3773633A4 (de) 2018-04-06 2022-01-26 The Regents of The University of California Verfahren zur behandlung von glioblastomen
CA3096838A1 (en) 2018-04-11 2019-10-17 Ohio State Innovation Foundation Methods and compositions for sustained release microparticles for ocular drug delivery
WO2020018700A1 (en) 2018-07-18 2020-01-23 Manzanita Pharmaceuticals, Inc. Conjugates for delivering an anti-cancer agent to nerve cells, methods of use and methods of making thereof
WO2020148612A1 (en) 2019-01-14 2020-07-23 Ignite Immunotherapy, Inc. Recombinant vaccinia virus and methods of use thereof
JP2022520220A (ja) 2019-02-14 2022-03-29 イグナイト イミュノセラピー インク 組換えワクシニアウイルスおよびその使用方法
BR112021019701A2 (pt) 2019-04-02 2021-12-14 Kenjockety Biotechnology Inc Anticorpos multiespecíficos para antígeno de câncer de bomba de efluxo e composições, reagentes, kits e métodos relacionados aos mesmos
CA3163805A1 (en) 2019-12-12 2021-06-17 Ignite Immunotherapy, Inc. Variant oncolytic vaccinia virus and methods of use thereof
JP7815595B2 (ja) 2020-01-29 2026-02-18 ウィリアム ロバート アラスーン リビング トラスト デイテッド オーガスト 29, 2016 抗ｍｄｒ１抗体およびその使用
CN116529267A (zh) 2020-06-04 2023-08-01 肯乔克蒂生物技术股份有限公司 Abcg2外排泵-癌症抗原多特异性抗体及其相关组合物、试剂、试剂盒和方法
WO2021247426A1 (en) 2020-06-04 2021-12-09 Kenjockety Biotechnology, Inc. Anti-abcg2 antibodies and uses thereof
US20220033784A1 (en) 2020-07-14 2022-02-03 Pfizer Inc. Recombinant vaccinia virus
JP7747741B2 (ja) 2020-09-02 2025-10-01 ウィリアム ロバート アラスーン リビング トラスト デイテッド オーガスト 29, 2016 抗ａｂｃｃ１抗体及びその使用
CA3203652A1 (en) 2020-11-13 2022-05-19 William Robert ARATHOON Anti-mrp4 (encoded by abcc4 gene) antibodies and uses thereof
EP4247829A1 (de) 2020-11-20 2023-09-27 R.P. Scherer Technologies, LLC Glycosid-dualspaltlinker für antikörper-wirkstoff-konjugate
CN112694458A (zh) * 2020-12-29 2021-04-23 重庆臻源红豆杉发展有限公司 一种10-去乙酰基巴卡亭ⅲ提取纯化方法
US20250051471A1 (en) 2021-12-13 2025-02-13 William Robert Arathoon Living Trust Dated August 29, 2016 Anti-Abcb1 Antibodies
WO2023159220A1 (en) 2022-02-18 2023-08-24 Kenjockety Biotechnology, Inc. Anti-cd47 antibodies

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2601676B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Procede de preparation du taxol et du desacetyl-10 taxol
FR2629819B1 (fr) * 1988-04-06 1990-11-16 Rhone Poulenc Sante Procede de preparation de derives de la baccatine iii et de la desacetyl-10 baccatine iii
FR2629818B1 (fr) * 1988-04-06 1990-11-16 Centre Nat Rech Scient Procede de preparation du taxol
US5019504A (en) * 1989-03-23 1991-05-28 The United States Of America As Represented By The Secretary Of Agriculture Production of taxol or taxol-like compounds in cell culture
US5175315A (en) * 1989-05-31 1992-12-29 Florida State University Method for preparation of taxol using β-lactam
US5136060A (en) * 1989-11-14 1992-08-04 Florida State University Method for preparation of taxol using an oxazinone
US5380916A (en) 1990-11-02 1995-01-10 University Of Florida Method for the isolation and purification of taxane derivatives
MX9102128A (es) 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US5279953A (en) * 1992-06-24 1994-01-18 Esca Genetics Corporation In vivo production of taxanes
FR2696463B1 (fr) * 1992-10-05 1994-11-25 Rhone Poulenc Rorer Sa Procédé d'obtention de la désacétyl-10 baccatine III.
FR2703049B1 (fr) * 1993-03-22 1995-04-21 Rhone Poulenc Rorer Sa Procédé de purification des taxoïdes.

Also Published As

Publication number Publication date
RU95110662A (ru) 1996-12-27
GR3022229T3 (en) 1997-04-30
US5393896A (en) 1995-02-28
HUT72678A (en) 1996-05-28
DE69307333D1 (de) 1997-02-20
HU9500969D0 (en) 1995-06-28
CA2470124C (fr) 2007-08-07
LTIP1398A (en) 1994-11-25
LV10620B (en) 1995-10-20
DK0663909T3 (de) 1997-01-27
CN1041310C (zh) 1998-12-23
NO951281L (no) 1995-04-03
SK43195A3 (en) 1995-08-09
AU680440B2 (en) 1997-07-31
HU225969B1 (en) 2008-01-28
LV10620A (lv) 1995-04-20
RU2108330C1 (ru) 1998-04-10
KR950703549A (ko) 1995-09-20
US5736366A (en) 1998-04-07
ZA937312B (en) 1994-04-25
CZ286593B6 (cs) 2000-05-17
ES2095672T3 (es) 1997-02-16
TW404944B (en) 2000-09-11
CZ286452B6 (en) 2000-04-12
FR2696462B1 (fr) 1994-11-25
CN1085552A (zh) 1994-04-20
SK280335B6 (sk) 1999-12-10
UA40601C2 (uk) 2001-08-15
PL173993B1 (pl) 1998-05-29
AU5115493A (en) 1994-04-26
CA2146248A1 (fr) 1994-04-14
EP0663909A1 (de) 1995-07-26
WO1994007881A1 (fr) 1994-04-14
EP0663909B1 (de) 1997-01-08
JPH08501791A (ja) 1996-02-27
DE69307333T2 (de) 1997-04-30
FI951590A0 (fi) 1995-04-04
FI951590L (fi) 1995-04-04
CZ84495A3 (en) 1995-09-13
LT3465B (en) 1995-10-25
FR2696462A1 (fr) 1994-04-08
KR100301238B1 (ko) 2001-11-22
CA2146248C (fr) 2006-12-12
GEP19981433B (en) 1998-10-30
NO951281D0 (no) 1995-04-03
PL308243A1 (en) 1995-07-24
CA2470124A1 (fr) 1994-04-14
MX9305770A (es) 1994-05-31
FI109797B (fi) 2002-10-15
JP3299753B2 (ja) 2002-07-08
NO310414B1 (no) 2001-07-02
EE03124B1 (et) 1998-10-15
NZ256449A (en) 1996-09-25

Similar Documents

Publication Publication Date Title
ATE147381T1 (de) Verfahren zur gewinnung von 10-deacetylbaccatin- iii
ATE148883T1 (de) Verfahren zur gewinnung von 10-deacetylbaccatin- iii
DE69825772D1 (de) Verfahren zur kristallisierung von sterisch gehinderten verbindungen
AT360447B (de) Verfahren zur aufbereitung von abwaessern, die nach der extraktion von kohleveredelungs- abwaessern mit organischen loesungsmitteln an- fallen
ATE181325T1 (de) Verfahren zur herstellung von ascorbinsäure
DE69729100D1 (de) Methoden zur selektiven acylierung von 10-deacetylbaccatin iii in der c-10 position
ATE223394T1 (de) Verahren zur selektiven acylierung von 10- deacetylbaccatin-iii in der c-10 position
EP0570824A3 (de) Verfahren zur selektiven Reduktion von ungesättigten organischen Verbindungen.
DE50008776D1 (de) Verfahren zur gewinnung von bakteriorhodopsin
DE3765524D1 (de) Verbessertes verfahren zur herstellung von metallorganischen verbindungen.
ATE366236T1 (de) Reinigungsverfahren von 1,4-butanediol mononitrat
ATE174333T1 (de) Verfahren zur herstellung von (s)-beta-hydroxy- gamma-butirolactone
DE69615562D1 (de) Verfahren zu extrahieren und isolierung von 10-desacetylbachatin iii
DE60013621D1 (de) Verfahren zur herstellung von 17-carboxy-androst-4-ene

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEFA Change of the company name